| Financial Year |
March 31 2023 |
| Monetary Funds |
348,924,207.43 |
| Held-for-trading Financial Assets |
56,743,409.25 |
| Notes Receivable |
193,317,501.91 |
| Accounts Receivable |
1,168,457,050.47 |
| Advances to Suppliers |
80,779,572.07 |
| Other Receivables |
72,357,521.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
129,608,863.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
18,646,748.21 |
| Other Current Assets |
74,529,849.42 |
| Total Current Assets |
2,468,230,028.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
10,037.88 |
| Long-term Equity Investment |
1,999,890.62 |
| Investment Properties |
113,464,364.87 |
| Fixed Assetes |
427,156,873.10 |
| Under-construction Projects |
75,258.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
140,208,274.09 |
| R&D expenses |
1,563,016.50 |
| Goodwill |
130,363,755.83 |
| Long-Term Deferred and Prepaid Expenses |
7,990,319.60 |
| Deferred Income Tax Assets |
144,023,469.60 |
| Other Non-Current Assets |
32,185,979.61 |
| Sub-Total of Non-Current Assets |
1,015,901,566.63 |
| Total Assets |
3,484,131,594.84 |
| Short-Term Loans |
384,644,041.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
296,824,923.86 |
| Accounts Payable |
531,494,176.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,087,380.82 |
| Taxes Payable |
12,254,776.75 |
| Interest Payable |
581,616.48 |
| Dividend Payable |
569,894.25 |
| Other payables |
31,929,921.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
242,121,958.68 |
| Other Current Liabilities |
132,099,976.52 |
| Sub-Total of Current Liabilities |
1,774,326,212.83 |
| Long-term Loans |
49,120,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
9,820,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
184,044.35 |
| Deferred Income Tax Liabilities |
16,254,189.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
109,443,776.91 |
| Total Liabilities |
1,883,769,989.74 |
| Paid-In Capital(Or Share Stock) |
855,125,963.00 |
| Capital Surplus |
1,709,483,687.82 |
| Surplus Reserve |
31,885,487.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,114,967,004.68 |
| Minority Stockholder's Interest |
123,107,413.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,477,254,191.14 |
| Owner's Equity（Stockholder's Equity） |
1,600,361,605.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,484,131,594.84 |
